BOSTON, Nov. 1 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE:SGP) today reported two data presentations supporting response guided...
KENILWORTH, N.J., Oct. 30 /PRNewswire-FirstCall/ -- Schering-Plough Corp. (NYSE:SGP) announced today the U.S. Food and Drug Administration (FDA...
CHICAGO, Oct. 30 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for CSCO, SGP, BHP, COST, and AEO. Seven Summits Strategic...
Standard & Poor's said online travel agent Priceline.com Inc. (PCLN) will replace Schering-Plough Corp. (SGP) in the S&P 500 index once...
The U.S. Federal Trade Commission on Thursday cleared Merck & Co.'s (MRK) $41 billion acquisition of Schering-Plough Corp. (SGP), but required...
Johnson & Johnson (JNJ) and Schering-Plough Corp. (SGP) announced that the next-generation arthritis therapy called Simponi showed...
KENILWORTH, N.J., Oct. 15 /PRNewswire-FirstCall/ -- Schering-Plough (NYSE: SGP) today announced that data on boceprevir, an investigational...
Australia's competition watchdog said Wednesday that it won't oppose Schering-Plough Corp.'s (SGP) US$41 billion takeover of Merck & Co...
BOXMEER, Netherlands, Oct. 8 /PRNewswire-FirstCall/ -- Intervet/Schering-Plough Animal Health today announced that it has initiated a multi-year...
An ailing U.S. health-care system might improve if U.S. reform legislation passes, but few health-industry executives and doctors gathered at a...
CHICAGO, Oct. 7 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for MSFT, SGP, AUY, WFMI, and ACH. Seven Summits Strategic...
A cash crunch among smaller drug developers has created more buying opportunities for large pharmaceutical companies, but Schering-Plough Corp.'s...
A Food and Drug Administration panel Monday narrowly backed the use of Schering Plough Corp.'s (SGP) Pegintron in patients with advanced melanoma...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads